Author Guidelines
 The Journal of Innovations in Cardiac Rhythm Management
Editor-in-Chief: John Day, MD, FHRS, FACC Print ISSN: 2156-3977 Frequency: Monthly Circulation: 9,895
|
|||
STATEMENT OF EDITORIAL PURPOSE
The Journal of Innovations in Cardiac Rhythm Management is a clinical journal that publishes peer-reviewed
articles on the latest developments impacting the field of cardiac arrhythmia management, including advancements in device therapy and evolutions within electrophysiology. Innovations in CRM will consider for publication, suitable articles related to the management of complex cardiac arrhythmias, heart failure, and sudden cardiac arrest that document the state of current practice.
We request that all manuscripts be submitted online at www.editorialmanager.com/innovationsincrm. Manuscript submissions should conform to the guidelines set forth in the ‘‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication,’’ available from www.ICMJE.org and most recently updated in April 2010.
English language help service: Upon request, MediaSphere Medical will direct authors to an agent who can check and improve the English of their paper (before submission). Please contact
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
for further information.
ETHICS
Studies should be in compliance with human studies committees and animal welfare regulations of the authors’
institutions and Food and Drug Administration guidelines. Human studies must be performed with the subjects’ written informed consent. Authors must provide the details of this procedure and indicate that the institutional committee on human research has approved the study protocol. If radiation is used in a research procedure, the radiation exposure must be specified in the Methods. Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in your paper.
Patients have a right to privacy. Therefore, identifying information, including patients’ images, names, initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If such consent is made subject to any conditions, the editorial office must be made aware of all such conditions.
Written consents must be provided to the editorial office on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Animal investigation must conform to the ‘‘Position of the American Heart Association on Research Animal Use,’’ adopted by the AHA on November 11, 1984. If equivalent guidelines are used, they should be indicated. The AHA position includes:
1) animal care and use by qualified individuals, supervised by veterinarians, and all facilities and transportation must comply with current legal requirements and guidelines;
2) research involving animals should be done only when alternative methods to yield needed information are not possible;
3) anesthesia must be used in all surgical interventions, all unnecessary suffering should be avoided and research must be terminated if unnecessary pain or fear results; and 4) animal facilities must meet the standards of the America. International Committee of Medical Journal Editors (“Uniform Requirements for Manuscripts Submitted to Biomedical Journals”) -- February 2006
EDITORIAL POLICIES
Innovations in CRM is an independent publication under the editorial control of MediaSphere Medical and its editorial board. Scientific rigor is enforced through a double blind peer-review process that evaluates suitability of a manuscript’s topic to the readership, originality of the presented material, and nature of the results. Manuscripts are examined by members of the editorial board. Communications about manuscripts will be sent after the review and editorial decision-making process is complete. The corresponding author will receive an acknowledgment e-mail upon receipt of the manuscript and notification of acceptance if applicable.
PEER REVIEW
Scientific rigor is enforced through a double-blind peer-review process that evaluates suitability of a manuscript’s topic to the readership, originality of the presented material, and nature of the results. Manuscripts undergo a double blind peer review.
COPYRIGHT
Copyright assignment is a condition of publication and authors are required to assign the copyright to the publisher prior to publication.
MANUSCRIPT FORMAT
All manuscripts are submitted through an online peer review system at www.editorialmanager.com/innovationsincrm. (Further information about the preparation of manuscripts is available in ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals, published by the International Committee of Medical Journal Editors at www.icmje.org.)
EDITORIAL MANAGER ONLINE PEER REVIEW SYSTEM
To log onto Editorial Manager, you must first have an online account. Please go to www.editorialmanager.com/
innovationsincrm, enter your username and password, and choose ‘author’. If you have not used the system before, please click the ‘register now’ button and follow the prompts to create a new account. You will be sent your new username and password via email. Please contact the Managing Editor, Lindsay Mazzagatti via email at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
or by phone at 856-438-5125 Ext. 125 with any questions.
SUBMISSION INSTRUCTIONS
After logging into your account, select ‘submit new manuscript’, select the article type from the pull-
down menu and enter your article title. A list of submission steps will appear on the left-hand side of your submission form. The mandatory fields are indicated in red. The final submission step is to upload the text files and digital figures that will be converted to a PDF for use by reviewers. These files must be free of author names, institutions and contact information. Figures MUST NOT include identifying patient information.
After you have attached all of your submission items, click on the ‘build PDF for my approval’ button. You will be directed to your ‘submissions waiting for author approval’ folder. You will be notified when your PDF is built and ready for approval. Once the PDF is built, click on the ‘view submission’ action link. This link opens your PDF. After you have reviewed your PDF, please close it and click on the ‘approve submission’ action link. Your submission will now be sent to Innovations in Cardiac Rhythm Management.
ESSENTIAL ELEMENTS FOR SUBMISSION
Title Page: The title should be concise and informative. Authors should be listed by first name, middle initial, last name, and degree(s). Institutional and departmental affiliations should be provided for each author. Give the name, mailing address, and e-mail address of the author responsible for correspondence.
Abstract and Key Words: The abstract should not be longer than 200 words and should highlight the significant content of the article. A list of 3 to 5 key words should be provided beneath the abstract for use by indexing and abstracting services. Optimally, these key words should be selected with the assistance of the National Library of Medicine’s medical subject headings (MeSH) browser, available at www.nlm.nih.gov/mesh/MBrowser.html.
References: Statements that are likely to be surprising or challenged should be referenced. Truisms (such as the statement, ‘Hypertension is often asymptomatic, but it can have serious long-range effects’) require no reference. A short list of suggested reading may be included in addition to specific references. References should be listed numerically in the order in which they are first mentioned in the article, not alphabetically. In contrast, suggested reading lists are ordered alphabetically. Use the American Medical Association style.
Journal articles: Asirvatham SJ: The isolated appendage: a new victim of collateral damage during atrial fibrillation ablation? Heart Rhythm 2010; 7:181-183.
Books: Josephson M. Clinical Cardiac Electrophysiology, Techniques and Interpretations. 4th ed. New York: Lippincott Williams & Wilkins; 2008: 383-395.
Chapters in books: Frank RR. Precancerous events in the human spleen. In: Arthur GV, ed. Liver and Disease. New York: Appleton-Century-Crofts; 1979:131’134.
Photos/Illustrations with Captions: If possible and as appropriate, each manuscript should include at least 1 table or text box that elaborates on the information in the article plus 1 or more camera-ready illustrations or photos that increase understanding of the text. Graphics should be submitted as slides or high-quality, glossy photo- graphic prints (no more than ‘8 x 10” in size). Each graphic must be numbered and cited in the text. Be sure each is labeled with the appropriate figure number, title of the manuscript, name of corresponding author, and arrow indicating the top. For photographic prints, type the information on a gummed label and affix it to the back of the photograph. All hard-copy materials will be returned to the author on request. Electronic submission of high-resolution illustrations or photos is preferred (via disk or e-mail). Adobe Illustrator or Photoshop EPS or TIFF files are preferred, using 300 dpi for halftones and 1200 dpi for line art. Captions for graphics should be no more than 50 words. Include magnification, stain, and other pertinent data where applicable.
Tables: Tables must be self-explanatory and supplement, not duplicate the text. Number brief titles in Arabic numerals according to the order they are mentioned in the text. Each table should be typed on a separate page and designed for economy of space and readability. Notes designated in the tables and all abbreviations should be defined in a footnote. Abbreviations should be identified in alphabetical order.
Drug Names and Dosing Information: Use the generic drug name in text and include in parentheses any trade names that would be more recognizable to clinicians. Drug-dosing information should include dose, frequency, route, and length of time the drug was administered.
Acknowledgments and Permissions: Illustrations and tabulated data from other publications must be acknowledged and must have received permission from the previous publisher. Provide the following information where applicable: author(s), title of article or chapter, title of journal or book, volume number, page number(s), month and year of publication, and publisher name and location. The publisher’s permission to reprint or adapt text or graphics must be submitted with the manuscript.
Disclosure/Conflict of Interest Statements: A statement acknowledging financial interest in products/ companies relevant to submitted research must be disclosed to the editors when the paper is submitted. Any financial interest which may be interpreted as a conflict of interest, including stock ownership, consultancies, patent licensing relationships, and other equity interests, must be disclosed in the cover letter. Please state, if no conflicts of interest exist.
Corresponding Author/Additional Authors: The corresponding author will receive all manuscript related correspondence via e-mail. NOTE: Case Studies are 3 authors or fewer. Authors are those who participated treating the patient. Others who were consulted mentioned in the acknowledgments section.
MANUSCRIPT FORMAT AND LENGTH
The following guidelines and formats are offered to assist authors in manuscript preparation. Conformation to these guidelines will not be the sole determinant of a manuscript’s acceptance or rejection. If the author feels that his or her topic must be addressed in a manner that does not conform to these guidelines (i.e., in more or fewer words and references), the author is encouraged to consult Innovations in CRM prior to manuscript submission.
Case Reports: Submissions should be 1500 to 2500 words in length, with an abstract, case images, as well as tables and/or figures to illustrate the presented case, along with appropriate references.
Original Research: Original research articles report the results of clinical research. Submissions should be approximately 5000 words in length and should include an abstract, tables and figures that support and explain the text of the submission, and approximately 25 references. Other acceptable article submissions in this area can discuss economic policy, ethics, law, and healthcare delivery.
Review Articles: Review articles should be written in a narrative style and should range from 5000 to 6000 words, including an abstract. Tables and figures should be utilized to expand the topic for the reader’s benefit. Subjects that require extended treatment may be presented as a series (Part I, Part II). References should not exceed 50 citations.
Unique Image Reviews: Unique Image Reviews are limited to 1 journal page. Adjunctive narrative and commentary should range between 450 to 500 words, with no more than 3 illustrations and up to 3 authors. 5 reference citations are allowed. ‘Featured Images’ are judged according to their visual quality, relevance, importance, uniqueness and effectiveness of their message, and applicability as an educational resource.
Interesting Electrocardiograms: This category enables clinicians to submit images showing interesting ECG cases, Holter recordings and monitor strips. A single image is suggested (however, multiple panels are allowed). Additionally, algorithmic or ladder diagrams or additional figures that explain the case are permitted. Images should be scan at 300 DPI. Preferred formats are JPEG and TIFF.
The text should be divided into 2 sections: (A) ECG description (up to 250 words) starting with1-2 sentences about the clinical case and (B) Points to Ponder (up to 350 words) which explain the “clinical context and relevance” of the ECG.
Caption for the figures should be included after the references. No more than 3 authors and 4 references are permitted.
Expert Commentaries: Submissions should consist of 1000 to 2000 words and up to 10 references. Authors are encouraged to submit tables and figures to complement the text.
Innovative Technique and Technology Features: The feature serves as a forum to spotlight emerging techniques and technologies employed within daily practice. The article may also include in-depth reviews showcasing new technologies. Articles should range from 2000 to 3000 words and include an abstract, table and figures, supporting images, as well as references.
Letters to the Editor: Letters should not exceed 400 words. Letters will be reviewed and are subject to editing. They should not contain original data or figures. If accepted for publication, a copy of the letter will be sent to the author(s) of the original article, if applicable. The author(s) will have an opportunity to respond with new material that will be considered for publication with the letter.
Digital Manuscript Enhancement: Interesting Electrograms, Unique Image Reviews, Case Reports, and Selected Review articles may receive digital integration on www.InnovationsInCRM.com, which enables authors to expand upon and enhance key elements of their print article and/or image reviews via an illustrative video forum.
Please consult the editor for the Digital Manuscript Enhancement participation guidelines and instructions.
Additional Manuscript Categories, Featured Sections, and/or Variations of the Above Formats: These variations are welcomed. The author is encouraged to consult Innovations in CRM regarding his or her recommendations, and the journal will consult with the board for acceptance.
QUESTIONS OR ASSISTANCE
For any questions about the editorial policy or manuscript submissions, please contact:
|
Lindsay Mazzagatti, Managing Editor |
 |